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ABSTRACT
Recent studies have shown that homologous recom-
bination (HR) requires chromatin repression as well
as relaxation at DNA double strand breaks (DSBs).
HP1 and SUV39H1/2 are repressive factors essen-
tial for HR. Here, we identify SETDB1 as an addi-
tional compacting factor promoting HR. Depletion
of HP1, SUV39, SETDB1 or BRCA1 confer identical
phenotypes. The repressive factors, like BRCA1, are
dispensable for the initiation of resection but pro-
mote the extension step causing diminished RPA or
RAD51 foci and HR in irradiated G2 cells. Depletion
of the compacting factors does not inhibit BRCA1 re-
cruitment but at 8 h post IR, BRCA1 foci are smaller
and aberrantly positioned compared to control cells.
BRCA1 promotes 53BP1 repositioning to the periph-
ery of enlarged foci and formation of a devoid core
with BRCA1 becoming enlarged and localized inter-
nally to 53BP1. Depletion of the compacting factors
precludes these changes at irradiation-induced foci.
Thus, the repressive factors are required for BRCA1
function in promoting the repositioning of 53BP1 dur-
ing HR. Additionally, depletion of these repressive
factors in undamaged cells causes diminished sis-
ter chromatid association at centromeric sequences.
We propose a model for how these findings may be
functionally linked.
INTRODUCTION
DNA non-homologous end-joining (NHEJ) and homolo-
gous recombination (HR) represent the two major DNA
double strand break (DSB) repair pathways in mammalian
cells. NHEJ functions throughout the cell cycle whilst HR
functions uniquely in late S/G2 phase when a sister chro-
matid is available as the source of an undamaged template
(1). Current models support the notion that NHEJ is ex-
ploited as the first option to repair DSBs in G2 phase
but if rejoining does not rapidly ensue, then resection is
initiated by CtIP and the MRE11/RAD50/NBS1 (MRN)
complex, which commits to repair by HR (2–4). Resec-
tion is proposed to arise via a two-step process with CtIP
and MRE11 endonuclease activity functioning in an initi-
ating event and MRE11 exonuclease activity, exonuclease
I and/or DNA2/BLM promoting the extension of resec-
tion (3,5–7). siRNA-mediated depletion of CtIP (siRNA
CtIP) or treatment with MRE11 endonuclease inhibitors
prevent HR but allows DSB rejoining to proceed by NHEJ;
in contrast, blocking the extension of resection, precludes
the opportunity to utilize NHEJ and confers a DSB repair
defect. Following RPA loading onto the ssDNA generated
by the initiation of resection, RAD51 subsequently replaces
RPA generating nucleoprotein filaments (4). The elongation
of resection enhances both RPA recruitment and RAD51
loading. An important further step in HR is the assimila-
tion of the displaced ssDNA onto the undamaged template
creating a Holliday junction and D-loop formation, which
can be considered to represent a step of synapsis. Finally,
post synapsis events include fill-in by polymerases, branch
migration and Holliday junction resolution.
BRCA1 also plays a critical role in the extension step of
resection (8,9). Current models propose that 53BP1, a dam-
*To whom correspondence should be addressed. Tel: +44 1273 678482; Fax: +44 1273 678121; Email: p.a.jeggo@sussex.ac.uk
Present address:
Yoko Katsuki, Radiation biology Centre, Department of Late Effects Studies, Kyoto University, Kyoto, Japan.
Atsushi Shibata, Advanced Scientific Research Leaders Development Unit, Gunma University, Gunma, Japan.
C© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
7932 Nucleic Acids Research, 2015, Vol. 43, No. 16
age response mediator protein, which is recruited to DSBs
in a choreographed manner at irradiation induced foci
(IRIF), functions to promote NHEJ by restricting resec-
tion. Recent studies have, in fact, suggested that phospho-
rylation of 53BP1 leads to the recruitment of RIF1, which
represents the effector factor restricting resection (10–12).
Whilst depletion of BRCA1 causes a defect in DSB repair
and impeded resection, co-depletion of BRCA1 and CtIP
allows DSB repair by NHEJ without resection suggesting
that BRCA1 functions downstream of CtIP to promote
the extension of resection. Intriguingly, loss of BRCA1 and
53BP1 or BRCA1 and RIF1 allows resection and HR to
proceed suggesting that BRCA1 functions to relieve the bar-
rier posed by 53BP1/RIF1. Consistent with this, two stud-
ies have shown that 53BP1 foci expand in G2 phase to create
a devoid core via a BRCA1-dependent process. This reposi-
tioning of 53BP1 is required for the extension step of HR.
Chromatin changes in the DSB vicinity are critical to
the DNA damage response (DDR). Whilst chromatin re-
laxation promoted by ubiquitination and DDR protein
recruitment has been well described, more recent studies
have provided evidence that compacting factors are also
recruited at least transiently at DSB sites and that they
are required for the completion of HR (13–19). Such fac-
tors have now been shown to include HP1, SUV39H1
and KAP1. However, their function during HR has not
been well examined. Here, we identify the histone methyl-
transferase, SETDB1 (also called ESET/KMT1E), which
also contributes to chromatin compaction via an ability
to methylate histone H3K9, as a further compacting pro-
tein being recruited to DNA DSBs and being essential for
the completion of HR (20–24). We then define the posi-
tion at which they function during HR. HP1, SUV39 and
SETDB1, like BRCA1, all function in the extension step
of resection, downstream of the initiation step. They are
dispensable for the initial recruitment of BRCA1 but their
depletion impairs the correct positioning of BRCA1 rela-
tive to 53BP1 and importantly prevents the two-fold en-
largement of 53BP1 at IRIF, which takes place in G2 cells
during HR (25,26). Interestingly, depletion of HP1, SUV39
or SETDB1 in undamaged cells reduces sister chromatin
association at centromeric regions. These findings define
SETDB1 as being a further component required for HR,
they show that the compacting factors have a downstream
role in HR and raise the possibility that they promote
synapsis or engagement of the damaged strand with the un-
damaged strand.
MATERIALS AND METHODS
Cell culture and irradiation
Human hTERT-immortalized fibroblasts (1BR3 hTERT)
and A549 cells were cultured in Minimum Essential
Medium (MEM), U2OS DR-GFP cells were cultured in
Dulbecco’s Modification of Eagles Medium (DMEM) sup-
plemented with 10% fetal calf serum (PAA laboratories),
2mM L-glutamine (Gibco), 100 unit/ml penicillin (Gibco)
and 100 unit/ml streptomycin (Gibco) at 37◦C in a humidi-
fied 95% air and 5% CO2 atmosphere. Cells were irradiated
by exposure to a Cs source. U2OS DR126 green fluorescent
protein (GFP) cells were kindly provided by Dr M. Jasin
(Gillingham, UK). A total of 3 M aphidicolin (APH) was
added to cells 30 min prior to ionizing radiation (IR) to pre-
vent S-phase cells from progressing into G2 (2,27). Mitotic
cells were excluded by their characteristic chromatin con-
densation and S phase cells by pan-nuclear H2AX stain-
ing. G2 cells were identified using CENPF staining (a G2
marker).
Small interfering RNA knockdown and plasmid transfection
Small interfering RNA (siRNA) mediated gene knock-
down was performed using Hyperfect transfection
reagent (Qiagen, Hilden, Germany) following the man-
ufacturer’s instructions. A total of 20 pM siRNA were
transfected per 2 × 104 cells. Cells were grown for
72 h before IR. SMARTpool siRNA oligonucleotides
from Dharmacon were used for Control, HP1,
HP1, HP1 , CtIP, EXO1 and BLM. SUV39H1 (5′-
ACCUCUUUGACCUGGACUAT-3′) and SUV39H2 (5′-
GAAGCUACCUUUGGUUGUUTT-3′) siRNA oligonu-
cleotides were obtained from Thermo Scientific. SETDB1A
(5′-GGAACUGGAGAAGAUGGAUUGUGUA-3′) and
SETDB1B (5′-CCGTGAAGCTATGGCTGCCTTAAGA-
3′) were from Dharmacon. BRCA1 (5′-
GGAACCUGUCUCCACAAAG-3′) siRNAs were
synthesized by Invitrogene (UK). Unless otherwise stated,
combined HP1/ siRNA oligonucleotides were used.
Combined SETDB1A/B and combined SUV39H1/H2
were used in all experiments.
The pCBASceI (from Dr M Jasin) plasmid was trans-
fected using GeneJuice transfection reagent (Novagen, Ger-
many) per 2.5 × 105 cells at 24 h post siRNA transfection.
Immunofluorescence and foci analysis
Cells grown on glass slides were fixed with paraformalde-
hyde (PFA) and permeabilized with 0.2% Triton X-100. For
RPA, RAD51 and BRCA1 staining, cells were pre-extracted
with 0.2% Triton X-100 in phosphate buffered saline (PBS)
before fixation. Cells were incubated with primary antibody
and followed by several washes with PBS before incubation
with secondary antibodies. Slides were then mounted by
Vectashield and analysed using a Nikon-e400 microscope.
Foci scoring were performed as described previously (2).
Images were taken by using an Applied Precision R© Delta
Vision R© RT Olympus IX70 deconvolution microscope and
softWoRx R© Suite software. The percentage of overlapping
foci was assessed using the Pearson coefficient of correla-
tion, which monitors overlap on a pixel-by-pixel basis (full
overlap is 1.0). Overlapping analysis was undertaken using
softWoRx R© Suite software. Z-stack imaging and 3D mod-
elling and foci volume quantification were done as described
previously (26). Foci scoring were performed as described
previously (2). Mean values represent 15–20 cells in each of
three experiments for each condition. The fluorescence in-
tensity was measured along a line drawn through the centre
of foci at different times after IR. Line intensity plots were
performed using the softWoRx R© suite software.
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Immunoblotting
For Immunoblotting, cells were lysed in high salt lysis
buffer, IPLB (50 mM Tris–HCl, 500 mM NaCl, 2 mM
EDTA, 2 mM EGTA, 25 mM NaF, 25 mM -glycerol phos-
phate, 0.1 mM NaOrthovanadate, 0.2% Triton X-100, 0.3%
NP-40, 10 U/ml of Benzonase nuclease, plus protease in-
hibitor cocktail (Roche, Basel, Switzerland) at 4◦C. Total
proteins were separated by 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis and transferred to ni-
trocellulose membranes. Membranes were blocked in 6%
non-fat dry milk and incubated with primary antibodies fol-
lowed by incubation with horse-radish peroxidase (HRP)
conjugated secondary antibodies and developed with En-
hanced Chemiluminescence (Western lightening Plus-ECL,
Perkin Elmer).
Antibodies for immunofluorescence and immunoblotting
The primary antibodies were: H2AX (1:800, Upstate
Technology, USA), 53BP1 (1:1000, Bethyl, Cambridge,
UK), RPA (1:100 for IF, Calbiochem, USA), RAD51
(1:200 for IF and 1:500 for IB, Santa Cruz Biotechnology,
USA), BRCA1 (1:100 for IF and 1:50 for IB, Santa Cruz),
HP1(,, ) (1:1000 for IB, Santa Cruz). HP1 (1:500 for
IB, Santa Cruz), RIF-1 (1:1000 Bethyl, Cambridge, UK),
SUV39H1/2 (1:300 for IB, Santa Cruz), SETDB1 (1:100
for IF, Abcam, UK, 1:1000 for IB, Cell Signalling Tech-
nology (CST), EXO1 and BLM (1:500, Santa Cruz), H3
(1:3000 Abcam, UK), H3K9 (1:3000 from Bethyl, Cam-
bridge, UK), -tubulin (1:3000, Sigma Aldrich, UK), HA
tag (1:1000, Abcam) and mouse monoclonal anti-Actin
(1:3000 from Sigma Aldrich, UK). The secondary antibod-
ies were FITC (1:200, Sigma Aldrich, UK), Cy3 (1:200,
Sigma Aldrich, UK) and Alexa Fluor 488 (1:400, Invitro-
gen, USA). Horseradish peroxidase (HRP) conjugated sec-
ondary antibodies were from Dako, UK.
Premature chromosome condensation (PCC) breakage
Premature chromosome condensation (PCC) analysis was
carried out as described previously (28). Briefly, 1BR3
hTERT cells were irradiated with 2 Gy IR after adding 3
M APH to prevent S-phase cells from progressing into G2
(2,27). Cells were treated with 50 ng/ml Calyculin-A for 30
min to induce PCC in G2-phase cells. Cells were then har-
vested at the indicated time points and processed for chro-
mosome break analysis. Chromosome breaks were scored
in 100 chromosomes.
HR and NHEJ mediated DR-GFP reporter assay using
fluorescene-activated cell sorting
U2OS DR-GFP and H1299 dA3–1 cells were used for
HR and NHEJ assays, respectively (3,29,30). Cells were
transfected with HA tagged I-SceI plasmid (pCBASceI)
or pEGFP-C3 empty vector 24 h after siRNA transfec-
tion. Forty-hours later, cells were trypsinized, resuspended
in PBS and transferred to ice in the dark. GFP expres-
sion was analysed using a fluorescence activated cell sorter
(FACSCanto, BD Biosciences) with FACS Diva software.
The GFP expressing population was normalized by the per-
centage of the population expressing enhanced green flu-
orescent protein (EGFP) as well as the magnitude of the
S/G2 phase population. For analysis of cell cycle distribu-
tion, cells were washed and resuspended in PBS containing
propidium iodide with RNase A (Sigma-Aldrich). Western
blot analysis was performed to assess I-SceI protein levels
after each siRNA treatment. Expression of HA-tagged I-
SceI was assessed by staining with HA tag antibody (31).
Laser micro-irradiation
To generate localized damage in cellular DNA with a
diode laser beam, cells were grown on glass bottom dishes
(IWAKI, Japan) and pre-sensitized with 15 M 5-bromo-2-
deoxyuridine (BrdU, Sigma-Aldrich, USA) in DMEM for
48 h at 37◦C. Laser micro-irradiation was performed using
a LSM700 laser scan 209 confocal microscope (Carl Zeiss)
equipped with a 405 nm LED laser diode (5 mW). The laser
was focused through a 40× Plan-Apochromat/1.3 oil objec-
tive and operated at 100% power output with 10 iterations.
The pixel dwell time to expose cells to the laser beam was
50 s. The regions in cellular DNA were irradiated in 10–
15 min. After laser irradiation, cells were incubated for 20
min at 37◦C and then fixed as described for IF analysis. All
laser-track images were acquired on an Axio Observer in-
verted microscope (Carl Zeiss) with AxioVision software.
Laser micro-irradiation using live cell imaging
U2OS cells were seeded onto 35 mm glass-bottom dishes
(MatTek) and transfected with pEGFP-SETDB1 con-
structs using Gene Juice transfection reagent. Cells were
grown for 48 h and, when used, 10 M ATMi (Tocris Bio-
science) added 1 h prior to the exposure to laser microirra-
diation. Cells were incubated with 10 g/ml Hoechst 34580
for 30 min at 37◦C before exposure. The Intelligent Imag-
ing Innovations spinning disk confocal microscopy with a
Yokogawa CSU-X1 on an Olympus IX-71 was used for
imaging. EGFP positive cells were irradiated with a 50 mW,
405 nm ultraviolet laser and channelled through a 60× ob-
jective. The UV laser was focused to an area of ∼12 ×
0.1m through the cell nuclei, and images were captured
at 10 s intervals following laser damage for a total time of
210. Signal intensity was quantified along the laser path us-
ing Slidebook 6 software. As controls, cells were exposed to
laser microirradiation without Hoescht treatment and no
signal was obtained in all cases.
Fluorescence in situ hybridization (FISH) assay
Cells were transfected with siRNA oligonucleotides and
subjected to immunofluorescence analysis to identify
G2 cells using CENPF antibody (27). Following im-
munoflourescence, cells were fixed with 3% PFA and per-
meabilized by HCL/Triton X-100. DNA was denatured
with 50% formamide and hybridized with the probe as de-
scribed by the manufacturer. DiGeorge II (10p14) probe
contains a probe specific to satellite DNA located at the
centromeric region on Chromosome 10 (labelled in green)
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(D10Z1). A minimum of 70 cells were imaged using an Ap-
plied Precision R© Delta Vision R© RT Olympus IX70 decon-
volution microscope and data analysed using softWoRx R©
Suite software.
Statistical analysis
All data were derived from three or four independent ex-
periments unless stated. Box plot was created by SigmaPlot
12.0. Statistical significance was determined using Mann–
Whitney U test or Student’s two-tailed t-test by SigmaPlot
12.0. Significance was indicated as *P < 0.05, **P < 0.01,
***P < 0.001.
RESULTS
HP1, SUV39 and SETDB1 are dispensable for NHEJ but
are required for HR
To facilitate an assessment of compacting factors on HR,
we first established siRNA mediated depletion conditions
that impair chromatin compaction without impeding cell
cycle progression. Unless otherwise stated, we examined
combined depletion of HP1 and  (called HP1), combined
depletion of SUV39H1/H2 (called SUV39), components
previously described as influencing HR, and combined de-
pletion of the histone methyl transferase, SETDB1A/B
(called SETDB1), which has not been previously examined
(15,19). Using the optimally chosen siRNA-mediated de-
pletion conditions, we observed reduced levels of each fac-
tor and diminished H3K9me3 levels without any substan-
tial reduction in the magnitude of G2 cells (Figure 1A, B
and Supplementary Figure S1A). To assess the influence on
DSB repair, we enumerated H2AX foci following exposure
to IR and depletion of each factor (siRNA HP1, SUV39
or SETDB1) (Figure 1C). siRNA BRCA1 was included as
a control to assess the contribution of HR to DSB repair.
To monitor DSB repair in cells irradiated and maintained
in G1 or G2 phase, we treated cells with APH, which in-
hibits the replicative polymerases, to identify S phase cells
and prevent their progression into G2 during analysis. G2
cells were identified using centromeric protein F (CENPF).
Extensive control experiments have shown that APH does
not induce DNA damage in G2 cells nor impede DSB repair
(2,27). We have previously shown that DSBs are repaired
with two component kinetics in G1 and G2 phase, and that
the slow process in G2 represents HR (2,27). siRNA HP1,
SUV39 or SETDB1 did not affect DSB repair at 2 or 8 h
post IR in G1 phase (Figure 1C). Since most DSB repair
in G1 occurs by c-NHEJ, we conclude that NHEJ is un-
affected by depletion of these proteins. In contrast, whilst
DSB repair was normal at 2 h post IR in CENPF+ G2 cells,
a subtle but statistically significant and reproducible DSB
repair defect was observed at 8 h. This defect was identi-
cal to that observed following siRNA BRCA1 (Figure 1D).
This represents the characterized defect observed following
loss of additional HR proteins, either by siRNA-mediated
depletion or in mutant mouse embryo fibroblasts (MEFs)
(2,27). This represents 15–20% of induced DSBs and is con-
sistent with the notion that NHEJ repairs the majority of
DSBs in G2 with fast kinetics whilst HR repairs a subset
of DSBs with slow kinetics. To substantiate that depletion
of SETDB1 confers a DSB repair defect using a procedure
that does not rely on chromatin changes, we also examined
chromosome breaks following treatment with calyculin A,
which causes premature chromosome condensation of G2
cells (28). We observed elevated chromosome breaks at 8 h
consistent with the DSB repair defect revealed by  -H2AX
analysis (Figure 1G). These findings provide suggestive ev-
idence that SETDB1 is required for HR in G2 phase and
supports studies reporting roles for HP1 and SUV39 in HR
(15,19).
To substantiate that HR is impaired following depletion
of the compacting proteins, we also examined the formation
of RPA and RAD51 foci in G2 cells at 2 and 8 h post IR
and observed an approximately two-fold defect in both end
points (Figure 2A, B, Supplementary Figure S1B and C).
This is similar to the typical phenotype observed following
siRNA BRCA1 (2). Finally, to consolidate an HR defect,
we employed a cell line harbouring an integrated construct
that allows HR to be monitored following the introduc-
tion of I-Sce1 induced DSBs (DR-GFP) (Figure 2E) (29).
Consistent with the findings above, siRNA HP1, SUV39 or
SETDB1, conferred a similar HR defect to that observed
following siRNA BRCA1. The cell cycle distribution anal-
ysed by FACS was not impacted by the siRNA treatments
and I-Sce1 was expressed at a similar level in all cells (Sup-
plementary Figure S2B and F). Since this represents the
first report that siRNA SETDB1 impedes HR, we sub-
stantiated the finding using two distinct siRNA SETDB1
oligonucleotides (Supplementary Figure S2C and SD) (the
data in Figure 2E and all subsequent analysis used the com-
bined oligonucleotides). Finally, using a similar assay to
monitor NHEJ, we observed a normal frequency following
siSETDB1, HP1 or SUV39 consistent with the notion that
HR is specifically affected (Supplementary Figure S2E and
F). Thus, we demonstrate that SETDB1 is dispensable for
NHEJ but identify it as an additional factor required for
HR.
HP1, SUV39 and SETDB1 function downstream of the ini-
tiation of resection
We next sought to dissect the stage during HR when the
compacting proteins function. The findings above suggest
that their depletion allows some but not extensive resec-
tion, a phenotype also observed following BRCA1 deple-
tion. Recent studies have demonstrated that resection oc-
curs via two steps; an initiation step involving CtIP/MRN,
which ensures a commitment to HR by preventing the usage
of NHEJ, and an elongation stage, which involves EXOI or
BLM/DNA2 (3,5–7). The findings above suggest that the
compacting proteins might promote the elongation of re-
section. We previously observed that inhibition of the initi-
ation of resection by siRNA CtIP enabled DSB repair to en-
sue by NHEJ (2,3). Thus, combined siRNA CtIP + BRCA1
or CtIP + BRCA2 relieves the DSB repair defect conferred
by siRNA BRCA1 or BRCA2 without relieving the defect
in resection or RAD51 loading (26). We, therefore, carried
out combined siRNA CtIP + HP1, SUV39 or SETDB1,
and examined DSB repair at 8 h in G2 phase cells, when
the contribution of HR to DSB repair can be optimally ob-
served. Consistent with the findings in Figure 1C, we ob-
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Figure 1. SETDB1, SUV39 and HP1 are dispensable for DSB repair in G1 phase but essential in G2. (A) 1BR3 hTERT cells were transfected with
siRNAs targeting control (CTR), SETDB1, SUV39, HP1/ and  and BRCA1. Knockdown of each component was verified by immunoblotting and
H3K9me3 levels assessed in whole cell extracts. (B) Quantification of the reduction in H3K9me3 levels. Note that in panels A and B we used combined
oligonucleotides for HP1/ and  . (C and D) Following siRNA mediated knockdown as indicated, 1BR3 hTERT cells were irradiated with 3 Gy and
H2AX foci enumerated at the indicated times in (C) G1 (CENPF−) and (D) G2 (CENP+) cells. (E and F) Representative images from experiments (C
and D). Staining for H2AX, CENPF and DAPI is as indicated. Asterisks denote statistically significant differences (P < 0.05); t-test). Results represent
the mean ± S.E.M of 3 experiments. (G) Chromosomal breaks were determined by premature chromosome condensation (PCC) breakage analysis. 1BR3
hTERT cells were subjected to siRNA mediated knockdown of control (CTR) and SETDB1 and irradiated with 2 Gy IR. Chromosomal breaks were
assessed at 8 h post IR. Data are represent the mean ± S.E.M of three experiments.
served a defect in the repair of a subset of DSBs following
siRNA HP1, SUV39 or SETDB1 (Figure 3A). Strikingly,
this repair defect was relieved when siRNA CtIP was com-
bined with depletion of any of the compacting factors, sim-
ilar to the findings with siRNA CtIP + BRCA1. Despite ef-
ficient DSB repair, combined siRNA CtIP + HP1, SUV39
or SETDB1 further reduced the level of RAD51 foci for-
mation substantiating that DSB repair does not ensue by
HR (Figure 3B). These findings consolidate the notion that
siRNA CtIP precludes the initiation of resection but allows
DSB repair to ensue by NHEJ in G2 phase. EXO1/BLM
function downstream of CtIP to extend the resected region
(3). We additionally examined whether siRNA EXO1/BLM
could influence the repair defect conferred by siRNA HP1,
SUV39 or SETDB1 (Figure 3A and Supplementary Figure
S3A). Consistent with the notion that EXO1/BLM func-
tion downstream of CtIP, we observed a repair defect fol-
lowing siRNA EXO1/BLM and the magnitude of the defect
was not changed following combined siRNA EXO1/BLM
+ HP1 /SUV39 or SETDB1, strongly suggesting the com-
pacting factors function in an epistatic manner to promote
the elongation of resection following its initiation. Thus, we
conclude that the three chromatin compacting factors are
dispensable for the initiation of resection but function to
promote the extension step.
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Figure 2. SETDB1, SUV39 and HP1 are required for the formation of RPA and RAD51 foci and for HR. (A and B) 1BR3 hTERT cells were transfected
with siRNAs targeting control (CTR), SETDB1, SUV39, HP1 and BRCA1, irradiated with 3 Gy and 2 h post IR, (A) RPA and (B) RAD51 foci were
quantified. RPA and RAD51 analysis at additional time points is shown in Supplementary Figure S1. Asterisks denote statistically significant differences
between control (CTR) and SETDB1, SUV39, HP1 knockdown cells. (P < 0.001;t-test). (C and D) Representative images from the above experiments:
(C) RPA and CENPF (D) RAD51 and CENPF as indicated. E. U2OS DR-GFP cells were transfected with siRNAs targeting control (CTR), BRCA1,
SETDB1, SUV39 or HP1 and 24 h later were re-transfected with pCBASceI. A GFP signal is generated following intrachromosomal gene conversion
following I-SceI-induced DSB formation. The percentage of GFP+ cells was measured by FACS 48 h after transfection with I-Sce1. GFP+ cells were
normalized to the percentage of EGFP positive cells and the level of the S/G2 population. All samples had a similar fraction of G2 phase cells and
expression of I-Sce1 was shown to be similar by Western blotting using an HA-tag on I-Sce1 (Supplementary Figure S2A, B). Asterisks denote statistically
significant differences (P<0.001; t-test). Results represent the mean ± S.E.M of 3 experiments.
RIF1 has been proposed as a factor inhibiting resec-
tion, being released from DSBs in G2 phase as HR ensues
(10–12). To assess the impact of the compacting factors on
RIF1, we examined RIF1 foci formation at times after IR in
G1 and G2 cells. Consistent with previous findings, siRNA
BRCA1 resulted in elevated RIF1 foci compared to that in
control cells most strikingly in G2 phase cells (10–12). Al-
though RIF1 was not present at all H2AX foci at 2 h in
G1 or G2 cells, there was a 1:1 relationship between RIF1
and H2AX foci by 8 h in control G1 but not G2 cells (Fig-
ure 3E). Following BRCA1 depletion, at 8 h in G2 phase
the ratio of H2AX: RIF1 foci was close to 1. In contrast,
siRNA of the compacting factors did not affect the level
of RIF1 foci compared to control cells in either G1 or G2
(Figure 3C and D). Since there are more DSBs remaining
at 8 h in G2 phase cells following siRNA HP1, SUV39 or
SETDB1 (Figure 3A), the number of RIF1 foci/H2AX
foci was slightly lower than in control cells although the ba-
sis for this is unclear (Figure 3E). Thus, we conclude that
depletion of the compacting factors exerts a distinct impact
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Figure 3. SETDB1, HP1 and SUV39 function downstream of the initiation of resection. (A) Following transfection of 1BR3 hTERT cells with siRNAs
targeting control (CTR), SETDB1, SUV39, HP1 with or without co-depletion with CtIP or EXO1/BLM, cells were irradiated with 3 Gy and H2AX
foci enumerated at the times indicated. Asterisks denote statistically significant differences (P<0.01; t-test). Knockdown of EXO/BLM is shown in Sup-
plementary Figure S3A. (B) Cells treated as above were enumerated for RAD51 foci at 2 h post IR. (C and D) Following siRNA mediated knockdown as
in panel A, cells were exposed to 3 Gy IR and stained with RIF-1 antibodies at the indicated times. RIF1 foci were counted in (C) G1 and (D) G2 cells.
(E) The ratio of RIF1/H2AX foci in G1 versus G2 cells at 2 and 8 h post 3 Gy IR. Data are the mean ± S.E.M of three experiments.
to siRNA BRCA1 and that the defect in resection does not
correlate with an inability to remove a barrier caused by
RIF1.
HP1, SUV39 and SETDB1 are dispensable for BRCA1 re-
cruitment but are required for the enlargement of BRCA1 foci
in G2
The findings above reveal that depletion of HP1, SUV39 or
SETDB1 confers a phenotype similar to that conferred by
siRNA BRCA1. This raised the possibility that the com-
pacting factors are required for BRCA1 recruitment. To ex-
amine this, we enumerated BRCA1 foci in G2 phase cells at
0.5 and 8 h post 3 Gy IR. The number of BRCA1 foci was
reduced at 8 versus 0.5 h, but was not significantly affected
by depletion of the compacting factors (Figure 4A). How-
ever, given that the number of H2AX foci was elevated at
8 h following depletion of HP1, SUV39 or SETDB1, the
number of H2AX foci with co-localized BRCA1 foci was
actually reduced (data not shown). Notwithstanding this, it
is evident that BRCA1 is recruited normally when the com-
pacting factors are depleted.
During this analysis, we observed that BRCA1 foci were
consistently smaller at 8 h following depletion of HP1,
SUV39 or SETDB1. We exploited Z-stacked immunoflu-
orescence imaging and 3D reconstruction to quantify the
size of BRCA1 foci and observed a significant increase in
BRCA1 foci size by 8 h in control G2 cells, which did not
occur following depletion of the compacting factors (Fig-
ure 4B). This increase in BRCA1 foci size during the pro-
gression of HR in G2 phase cells is consistent with our pre-
vious analysis (25,26). Thus, the reduction in numbers of
BRCA1:H2AX foci numbers discussed above may be a
consequence of inefficient estimation of BRCA1 foci num-
bers due to their small size.
Collectively, these findings provide preliminary evidence
that the compacting proteins are dispensable for the initial
recruitment of BRCA1 but impede the normal enlargement
of BRCA1 foci.
During this analysis, we observed that the centre of
BRCA1 and 53BP1 foci did not appear to precisely co-
localize as they did in control cells (see Figure 4C for rep-
resentative images). Using Z-stacked immunofluorescence
imaging and 3D reconstruction, we examined the nature of
damage response foci at 8 h post IR and in control cells and
observed that by 8 h post IR, a devoid core within 53BP1
foci was evident in the majority of foci (Figure 4C). Al-
though slightly less evident, a devoid core was also observed
within some of the BRCA1 foci and BRCA1 was located
internally to 53BP1, which is consistent with our own and
previous work examining the structure of damaged induced
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Figure 4. SETDB1, SUV39 and HP1 are dispensable for BRCA1 recruitment but required for its enlargement and localization within IRIF. (A) BRCA1
foci were enumerated in 1BR3 hTERT cells at 0.5 and 8 h in G2 cells post 3 Gy IR following the indicated siRNA-mediated knockdown. Note that Delta
Vision microscopy was used for this analysis in contrast to Figure 1. The number of foci (H2AX and BRCA1) is elevated when enumerated using Delta
Vision microscopy due to the better delivery of the light source to the objective lens and enhanced contrast. Thus, foci numbers here do not correlate with
those in Figure 1 although the relative impact of siRNA remains consistent. (B) BRCA1 foci size was analysed in G2 cells after 3 Gy IR at the indicated
time points using softWoRx R© suite software. Data are the mean ± S.E.M of three experiments. Asterisks denote statistically significant differences (P <
0.05; t-test). (C) 1BR3 hTERT cells were transfected with siRNAs targeting control (CTR) or SETDB1, SUV39, HP1, 48 h later cells were irradiated with
3 Gy and co-stained with BRCA1 and 53BP1 antibody at 8 h post IR. Images were taken by Delta Vision microscopy. In the bottom panel, representative
3D images were generated by the softWoRx R© suite software. Panels shows representative images of 53BP1 and/or BRCA1 at 8 h post IR. Top two lines
of the bottom panel show two images after siCTR and the bottom row after siRNA SETDB1 (siSETDB1). Images highlight lack of overlap of 53BP1
and BRCA1 foci after knockdown of SETDB1 and the lack of a devoid core. Knockdown of the other compacting factors gave images similar to those
after siRNA SETDB1. Note that the top images show a 2D representation and not all foci are therefore observed. (D) The overlap of BRCA1 and 53BP1
foci was quantified in deconvolved Delta Vision 2D images by the softWoRx R© suite software. The result indicates percentage of overlapping foci between
(BRCA1+ 53BP1) relative to total BRCA1 foci. The Pearson coefficient of correlation monitors how closely two intensities overlap on a pixel-by-pixel
basis (full overlapping is 1.0). Asterisks indicate statistical difference (P < 0.05; t-test).
foci (Figure 4C) (25,26). Following depletion of any of the
three compacting factors, a devoid core was not evident
in any foci, and it appeared that 53BP1 and BRCA1 were
frequently offset (Figure 4C). We used Delta Vision image
analysis software to quantify the percentage of foci where
53BP1 and BRCA1 were overlapping (and hence by deduc-
tion were offset). The software assessed foci as overlapping
when a pre-determined level of overlap was observed, which
did not represent precise localization of BRCA1 in the cen-
tre of 53BP1 as shown in control cells in Figure 4C. Thus,
our estimate of foci that do not overlap likely represents an
underestimation of the aberrant relative position of BRCA1
versus 53BP1 after siRNA of the compacting proteins. Since
the number of BRCA1 foci was less than that of 53BP1, we
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calculated the ratio of BRCA1 and 53BP1 foci assessed by
the software to be ‘overlapping’ divided by the total num-
ber of BRCA1 foci (Figure 4D). This analysis clearly re-
vealed that the relative positioning of BRCA1 and 53BP1
was changed by depletion of the compacting proteins. This
was evident at 0.5 h post IR but became more evident by 8
h when, in control cells BRCA1 and 53BP1 foci have under-
gone enlargement.
Since, in control cells 53BP1, BRCA1 and H2AX form
concentric foci, albeit of different diameters and with
devoid cores of different diameters, we aimed to assess
whether 53BP1 or BRCA1 overlapped with H2AX fol-
lowing siRNA SETDB. We used the same procedure de-
scribed above, namely assessing the percentage of overlap-
ping BRCA1 or 53BP1 foci with H2AX foci relative to
the total number of H2AX foci. With control cells, we
observed a high level of overlap (>80%) for 53BP1 and
H2AX at 0.5 and 8 h and for BRCA1 and HAX at 8 h
(Supplementary Figure S3B and C). BRCA1 and H2AX
overlap at 0.5 h was slightly lower since BRCA1 foci have
not completely formed at this early time point (Supplemen-
tary Figure S3C). This demonstrates that despite the pres-
ence of the devoid cores and different diameters of the foci,
there is high ‘overlap’ assessed by this procedure, most likely
due to limitation in resolution. Following siSETDB1, how-
ever, the overlap for 53BP1 and H2AX was substantially
lower than observed in controls cells whilst being similar
for BRCA1 and H2AX (Supplementary Figure S3B and
C). This strongly suggests that 53BP1 is the DDR protein
that becomes incorrectly positioned at the IRIF in the ab-
sence of the compacting factors. The underlying basis is not
fully understood but suggests that as BRCA1 foci enlarge in
G2 phase, 53BP1 becomes inappropriately positioned when
chromatin compaction is aberrant.
HP1, SUV39 and SETDB1 are required for the repositioning
of 53BP1 to the periphery of enlarged foci during HR
To quantify these changes within the foci, we used our previ-
ously described procedure where fluorescence intensity pro-
file images were quantified along a line drawn through the
centre of the foci at 8 h post IR (26) (Figure 5A). Consistent
with previous findings, we observed that at 0.5 h post IR,
53BP1 has a monomodal distribution but by 8 h a bimodal
distribution is observed with a core of reduced 53BP1 inten-
sity (Figure 5A; 0.5 h images are not shown but see (26)).
This is accompanied by an overall increase in width of the
53BP1 foci demonstrating the repositioning of 53BP1 to the
periphery of enlarged foci. Of note, we have previously ob-
served that the enlargement and creation of a devoid core
represent distinct steps since siRNA POH1 (a component of
the proteasome) allows expansion of 53BP1 but the devoid
core does not form (26). We note also that quantitative anal-
ysis of 53BP1 intensity demonstrates a core of reduced in-
tensity (Figure 5B). However, analysis of individual decon-
volved images demonstrate a more marked 53BP1-devoid
core. We have, therefore used this terminology in the en-
suing discussion, although formally we cannot distinguish
between a devoid core versus a core of reduced intensity.
Strikingly, following siRNA HP1, SUV39 or SETDB1 we
failed to observe the repositioning of 53BP1 and, impor-
tantly there was no evidence for the formation of a 53BP1
devoid core (Figure 5C–E). We also assessed the position
of BRCA1 using the same procedure by aligning the centre
of the BRCA1 peak relative to the 53BP1 peak. This analy-
sis revealed that, whereas in control cells the BRCA1 peak
lies between the two 53BP1 peaks, following depletion of
HP1, SUV39 or SETDB1, the peak of BRCA1 intensity was
offset relative to the 53BP1 peak. Further, the width of the
53BP1 foci at 8 h post IR following siRNA HP1, SUV39 or
SETDB1 was reduced relative to that in control cells (Fig-
ure 5F). Although less marked, the width of BRCA1 foci
was also reduced, consistent with the findings above that
BRCA1 foci do not enlarge by 8 h following depletion of
the compacting factors as they do in control cells. Although
analysis of individual images of BRCA1 in control cells sug-
gested a core of reduced intensity (Figure 4C), this was not
evident from the intensity distribution analysis (Figure 5B),
most likely because the latter procedure represents the aver-
age of multiple foci and is, therefore, less sensitive in detect-
ing a reduced core. In these images, the fluorescence was set
to an arbitrary level to give a similar size peak of BRCA1
and 53BP1 to assess distribution. We also estimated the in-
tensity of BRCA1 at foci following depletion of the com-
pacting factors relative to that in control cells, to enable
a comparison of levels. This analysis demonstrated the re-
duced intensity of BRCA1 at IRIF following siRNA of the
compacting factors, a feature that was evident throughout
the analysis and that likely contributes to the reduced de-
tection of BRCA1 foci (Figure 5G).
SETDB1 is recruited to DNA damage sites
In addition to being required for HR, previous studies have
reported that HP1 and SUV39 are recruited to DSB sites
(15,17,19). Since SETDB1 represents a novel component re-
quired for HR, we examined whether, like the other com-
pacting factors, it is also recruited to the sites of DNA dam-
age. Due to limitations of the available SETDB1 antibod-
ies and a level of chromatin bound SETDB1 without DNA
damage, we were unable to reliably detect SETDB1 recruit-
ment to H2AX foci. As an alternative procedure to mon-
itor a role for SETDB1 in the DDR, we used a ChIP-based
assay following introduction of a site-specific DSB (Figure
6A). As expected, following I-Sce1 expression, chromatin
bound H2AX increased. Strikingly, we observed a similar
increase in chromatin bound SETDB1 (Figure 6B). Whilst
this does not verify that SETDB1 is specifically recruited to
DNA damage sites, it provides initial evidence that the level
of chromatin bound SETDB1 increases after DNA damage.
Next, we examined the recruitment of SETDB1 to the
sites of DNA damage induced by 405 nm laser irradia-
tion in photosensitized cells. First, we examined the recruit-
ment using -SETDB1 antibodies at 20 min post laser ir-
radiation. At this time point, SETDB1 recruitment to laser
tracks could be readily observed (Figure 6C). Recruitment
was observed in all cells with laser-induced damage as-
sessed by H2AX and was not specific to G2 cells (data not
shown). Since HP1 and p150CAF-1 are also recruited to
405 nm laser-induced DNA damage (15,17), we examined
whether SETDB1 recruitment is dependent upon HP1 and
p150CAF-1. We observed substantially diminished recruit-
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Figure 5. SETDB1, SUV39 and HP1 are required for the repositioning of 53BP1 to the periphery of IRIF during HR. (A) Representative images of
53BP1 (red) and BRCA1 (green) foci used to generate the analysis in panels A–D. This figure shows how a line is drawn through the foci. Following siRNA
control, 53BP1 entirely surrounds BRCA1 whereas following siRNA SETDB1 (siSETDB1) the two foci are off set. (B) A549 cells were depleted with
siRNAs targeting control (CTR), SETDB1, SUV39, HP1, irradiated with 3 Gy IR and 48 h later co-stained with BRCA1 (green) and 53BP1 (red). The
fluorescence intensity was quantified along a line drawn through the centre of 53BP1 foci to provide a fluorescence intensity profile using the softWoRx R©
suite software. In control cells 53BP1 has a bimodal distribution with BRCA1 being localized within the core of diminished intensity. (C, D and E) Similar
quantification was carried out following siRNAs targeting control (CTR), SETDB1, SUV39 and HP1. The results show a monomodal distribution of
53BP1. The width of the peak for 53BP1 and BRCA1 are smaller than in the siCTR sample and the BRCA1 peak is off set relative to the 53BP1 peak. (F)
Quantification of the width of 53BP1 foci. The foci width was determined by measuring the distance between the outer edges of the peaks at 50% intensity.
(G) BRCA1 intensity following siRNA SETDB1, SUV39 or HP1 was reduced compared to control siRNA. In panels A–D, the maximum Y axis value
was automatically set to the maximum fluorescence intensity of 53BP1 (left axis) and BRCA1 (right axis) giving the same size peak irrespective of absolute
intensity. Note that BRCA1 intensity is about 10-fold less than the 53BP1 intensity. This panel shows the comparative intensity of BRCA1 following siRNA
targeting control (CTR), SETDB1, SUV39 or HP1. Asterisks shows statistically significant difference between control and siRNA SETDB1, SUV39 or
HP1 (P < 0.005; t-test).
ment of SETDB1 following siRNA HP1 or p150CAF-1
(Figure 6D) suggesting that efficient SETDB1 recruitment
requires HP1 and p150CAF-1. Finally, previous work sug-
gested that HP1 is only transiently retained at laser tracks.
To examine the kinetics of SETDB1 retention, we used live
cell imaging to monitor the retention of EGFP-SETDB1
following its expression in U20S cells. Significantly, we ob-
served optimal recruitment of SETDB1 between 5–10 min
post treatment, with a gradual decrease over the following
30 min (Figure 6E), kinetics which appear similar to that
reported for HP1 (15). At 20 min post laser treatment, sub-
stantial SETDB1 is still retained, consistent with our find-
ings above, although the recruitment peak has been passed.
Collectively, these findings show that SETDB1 is recruited
to the sites of DNA damage via a process that, at least to
some degree, requires HP1.
Finally, to gain evidence that SETDB1 might be a fur-
ther component of the DDR, we examined whether ATM
was required for its recruitment. In our approach using
-SETDB1 antibodies at 20 min post laser treatment, we
observed that SETDB1 recruitment to laser tracks is sub-
stantially diminished in the presence of an ATM inhibitor,
KU55933 (Figure 6F). As reported previously, the forma-
tion of H2AX is reduced in the presence of the ATM in-
hibitor, consistent with the notion that DNA-PK can phos-
phorylate H2AX when ATM is inhibited but does so less
efficiently than ATM (32). The recruitment of SETDB1
was almost abolished, however. To examine, the kinetics
of SETDB1 recruitment in the presence of ATMi, we car-
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Figure 6. SETDB1 is recruited to DSB sites. (A) The pCBASce1 plasmid used to assess protein localization. F1 and F2 represent a primer pair used in panel
B. The primers are located 500 bp upstream of the I-SceI recognition site. (B) HeLa DR-GFP cells were transfected with or without pCBASceI plasmid and
processed for the ChIP assay using ––yH2AX and -SETDB1 antibodies at 24 h post-transfection. DNA was recovered from immunoprecipitates and
quantified by real time quantitative PCR. (C) U2OS cells were transfected with siRNA targeting control (CTR) or SETDB1. Cells were pre-photosensitized
with 10 pM BrdU for 48 h and irradiated with a 405 nm laser. Twenty minutes post-micro irradiation, cells were fixed after pre-extraction and stained for
H2AX, SETDB1 and DAPI. (D) U2OS cells were transfected with siRNAs targeting control (CTR), p150CAF-1 (CAF-1) or HP1 and 48 h later, cells
were microirradiated as in C. Twenty minutes later, cells were pre-extracted, fixed and stained for SETDB1, H2AXor DAPI . (E) U2OS cells transfected
with the pEGFP-SETDB1. After 48 h transfection cells were irradiated with a 405 nm laser. A total of 10 M ATM inhibitor (KU-55933) was added
to the cells 1 h prior to microirradiation. The GFP signal intensity was quantified along the laser track in untreated and ATMi-treated cells expressing
pEGFP-SETDB1. GFP-signal intensity was monitored in 40 cells for 35 min post IR. Results represent the mean ± S.E.M of three experiments. (F) U2OS
cells were treated with 10 M ATM inhibitor (KU-55933) for 1 h prior to microirradiation as in panel C. Twenty minutes later, cells were processed for
immunofluorescence using -SETBD1 or ––yH2AX antibodies. Reduced  -H2AX formation and SETDB1 accumulation was observed in cells treated
with ATMi compared to control cells.
ried out live cell imaging as described above and observed,
surprisingly, that SETDB1 is initially recruited normally to
laser tracks but is rapidly lost within 10 min (Figure 6E).
Depletion of HP1, SUV39 or SETDB1 impairs sister chro-
matid cohesion
The findings above suggest that the compacting factors
function in a step of HR downstream of the initiation of
resection. A critical step during HR is engagement of the
damaged strand with the sister chromatid. Whilst the sister
chromatid may be readily available during the events pro-
ceeding replication, they may be more distant in G2 phase
cells. We considered whether chromatin compaction might
enhance sister association in G2 phase cells. To assess this,
we examined the distance between sister chromatids in con-
trol cells and following siRNA of HP1, SUV39 or SETDB1.
To assess sister chromatid association, we used a probe lo-
cated in the centromeric region of chromosome 10 for FISH
analysis and quantified the distance between the two foci in
G2 phase cells (33). Strikingly, we observed enhanced sepa-
ration of the centromeric probes following siRNA of HP1,
SUV39 or SETDB1 (Figure 7A–C).
BRCA1 has also been reported to function in the for-
mation of pericentric heterochromatin (34). Thus, we also
assessed the impact of siRNA BRCA1 on sister chromatin
association using the same procedure. Although we consis-
tently observed a small increase in sister separation follow-
ing siRNA BRCA1 (see Figure 7D), this difference varied
between experiments and was clearly substantially smaller
than observed following siRNA of the compacting proteins.
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Figure 7. Depletion of HP1, SUV39 or SETDB1 impairs sister chromatid association. (A, B, C and D) The distance between sister chromatids was
quantified in 1BR3 hTERT G2 cells transfected with siRNAs targeting control (CTR), SETDB1 (A), SUV39 (B), HP1 (C) and BRCA1 (D) using IF-
FISH assay. The SoftWoRx R© suite software was used to measure distance between the sister chromatids. The distance between the outer edges of the foci
were measured. The distances between signals were measured from three independent experiments and the distribution was plotted as a histogram. Each
individual experiment gave a similar difference in distribution. The box plot represents the corresponding clustered columns. Distribution counts from the
FISH experiments were analysed using Mann–Whitney Rank Sum Test. (E) IF-FISH images for control siRNA and siRNA SETDB1. Not that since then
two FISH spots frequently overlap, the distance between the outer edges were measured. The distances do not, therefore, represent actual sister separation
differences but provide a readout for sister association.
DISCUSSION
Previous studies have shown that the progression of HR re-
quires processes that enhance chromatin decompaction as
well as the recruitment of factors required for chromatin
repression (19). Whilst there may be temporal differences
in the requirement for compaction versus relaxation, the
changes may also be distinct at specific locations relative
to the DSB site. The requirement for chromatin modifica-
tions such as ubiquitylation has been well analysed (35).
However, although recent studies have provided evidence
that factors, including HP1, SUV39H1 and KAP1, that
are required for chromatin compaction play an essential
role in HR, a dissection of their precise function has not
been undertaken (15,19). Here, we report that SETDB1 is
a further compacting factor required for HR. Like siRNA
HP1/ or SUV39, siRNA SETDB1 results in a dimin-
ished level of H3K9me3. SETDB1 recruitment and reten-
tion at laser tracks occurs with similar kinetics to that of
HP1 and SUV39H1 (15,19) and, like HP1, is dependent
upon p150CAF-1. However, surprisingly, whilst the reten-
tion of SUV39 at laser tracks is enhanced following ATM
inhibition, SETDB1 is prematurely released when ATM is
inhibited (19). SUV39’s release from damage sites has been
proposed to depend upon the phosphorylation of KAP1 by
ATM. The basis for the distinction with SETDB1 is cur-
rently unclear and requires further investigation. However,
our focus in this study lies on the role of the compacting pro-
teins during HR. To this end, we provide evidence that their
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depletion confers a remarkably similar phenotype suggest-
ing that they function in a similar process, which we propose
necessitates chromatin repression. Whilst these factors are
all required for heterochromatin formation, we do not dis-
tinguish here whether they simply enhance chromatin com-
paction at DSB sites versus generating a heterochromatic
microenvironment.
Previous studies have shown that in G2 phase cells, the
progression of resection involves an initiation step involv-
ing CtIP/MRN (4,5). If this process is prevented by siRNA
CtIP, then, although HR cannot take place, DSB repair can
ensue by NHEJ suggesting that this initiation step repre-
sents an event committing to HR (2,3). Our findings reveal
that the compacting factors are dispensable for the initia-
tion of resection. The progression of resection and efficient
loading of RAD51 necessitates multiple changes at damage
induced foci, however. BRCA1 is essential for this step of
HR and functions to relieve the inhibitory impact of 53BP1
(8,9). The compacting factors appear to be required dur-
ing this step of HR. Intriguingly, studies have proposed that
RIF1 is the final effector that inhibits resection via its inter-
action with 53BP1 (10–12). However, loss of the compact-
ing factors does not result in enhanced levels of RIF1 foci in
G2 phase cells as observed following depletion of BRCA1,
showing that RIF1 is not the sole factor impeding the exten-
sion step of HR. This raises the possibility that 53BP1 can
be inhibitory to resection in a RIF1-independent manner.
Our findings strongly suggest that the compacting fac-
tors are not essential for BRCA1 recruitment to DSBs but
they impede its correct localization relative to 53BP1 and its
function in promoting the repositioning of 53BP1 as HR en-
sues. Since BRCA1 intensity at foci increases as HR ensues
due to its enlargement and repositioning, the BRCA1 foci
appear reduced in size and numbers at 8 h in G2 cells follow-
ing loss of the compacting factors. This is consistent with,
but extends, previous studies showing that BRCA1 foci are
reduced in number following siRNA HP1. Since a reduc-
tion in foci size could readily explain the observed decrease
in foci numbers due to scoring inaccuracies, we propose that
the primary impact of loss of compacting factors is a failure
to promote the repositioning of BRCA1 as HR progresses.
The progression of HR must involve engagement of the
damaged strand with the undamaged template. We consid-
ered that the failure to progress resection and Rad51 assim-
ilation following depletion of the compacting factors could
potentially reflect a failure to engage with the sister homo-
logue. This hypothesis was in part prompted by the find-
ing that 53BP1 foci undergo a two-fold enlargement during
HR, which we considered could represent its transfer onto
the undamaged strand (36). This two-fold enlargement does
not occur in G1 phase cells. Given this possibility, we eval-
uated whether chromatin compaction might influence the
association between sister chromatids. Strikingly, we found
that in undamaged cells, depletion of any of the three com-
pacting factors caused an increase in the separation between
sister chromatids. Moreover, the magnitude of this effect
generally paralleled the impact of these factors in our HR
assays (siRNA HP1 and SUV39 causing a greater impact
than siRNA SETDB1), and most notable in diminishing
BRCA1 intensity at foci, raising the possibility of a causal
relationship.
Based on these findings, we propose the following model.
Following initiation, resection progresses in a 5′ to 3′ direc-
tion followed by loading of RAD51. This promotes assim-
ilation of the damaged strand onto the undamaged strand,
which is required for further extension of resection, further
loading of RAD51 and the completion of HR. These lat-
ter steps also require chromatin changes on the undamaged
template, including the recruitment of 53BP1. BRCA1 trig-
gers this process, which requires new ubiquitylation events
and proteasome-mediated degradation (26). Importantly,
this step also necessitates the ability to engage with the sis-
ter homologue. We propose that it is this step that is pro-
moted by the transient recruitment of chromatin repressive
factors. This is consistent with our previous suggestion that
the enlargement of 53BP1 represents its association on the
undamaged strand, which is likely to require appropriate
sister chromatin cohesion (26,36). Currently, we have only
shown that diminished chromatin compaction as evidenced
by reduced H3K9me3 levels causes enhanced sister separa-
tion at centromeric regions, where compacting factors are
high. Given that the repressive factors are recruited to DSB
sites, we propose that they may serve to transiently enhance
sister association at such sites. Although currently only cor-
relative, verification of this role necessitates approaches to
allow sister chromatid cohesion at DSBs to be monitored.
In summary, we demonstrate that SETDB1 is a further
compacting factor required for HR and that siRNA of
SETDB1 confers an HR defective phenotype identical to
that conferred by depletion of HP1 or SUV39, which also
reflect the phenotype conferred by loss of BRCA1. We de-
fine the stage during HR when the compacting factors func-
tion showing that they are dispensable for the initiation of
resection but are required to promote enlargement of 53BP1
foci, which is itself required for the progression of resection.
They are dispensable for BRCA1 recruitment but impede its
enlargement and correction positioning within foci. Finally,
we demonstrate that a distinct impact of depletion of these
compacting factors is to enhance the separation of sister
chromatids at centromeric regions. Based on this finding,
we propose a model for how the compacting factors may
promote sister chromatid engagement during HR.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENT
We thank Frank Rauscher III for materials useful for this
work.
FUNDING
Medical Research Council [MR/J001007/1]. The open ac-
cess publication charge for this paper has been waived by
Oxford University Press––NAR Editorial Board members
are entitled to one free paper per year in recognition of their
work on behalf of the journal.
Conflict of interest statement. None declared.
7944 Nucleic Acids Research, 2015, Vol. 43, No. 16
REFERENCES
1. Moynahan,M.E. and Jasin,M. (2010) Mitotic homologous
recombination maintains genomic stability and suppresses
tumorigenesis. Nat. Rev. Mol. Cell. Biol., 11, 196–207.
2. Shibata,A., Conrad,S., Birraux,J., Geuting,V., Barton,O., Ismail,A.,
Kakarougkas,A., Meek,K., Taucher-Scholz,G., Lobrich,M. et al.
(2011) Factors determining DNA double-strand break repair
pathway choice in G2 phase. EMBO J., 30, 1079–1092.
3. Shibata,A., Moiani,D., Arvai,A.S., Perry,J., Harding,S.M.,
Genois,M.M., Maity,R., van Rossum-Fikkert,S., Kertokalio,A.,
Romoli,F. et al. (2014) DNA double-strand break repair pathway
choice is directed by distinct MRE11 nuclease activities. Mol. Cell,
53, 7–18.
4. Symington,L.S. and Gautier,J. (2011) Double-strand break end
resection and repair pathway choice. Annu. Rev. Genet., 45, 247–271.
5. Mimitou,E.P. and Symington,L.S. (2011) DNA end
resection–unraveling the tail. DNA Repair (Amst), 10, 344–348.
6. Nimonkar,A.V., Genschel,J., Kinoshita,E., Polaczek,P.,
Campbell,J.L., Wyman,C., Modrich,P. and Kowalczykowski,S.C.
(2011) BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN
constitute two DNA end resection machineries for human DNA
break repair. Genes Dev. 25, 350–362.
7. Zhu,Z., Chung,W.H., Shim,E.Y., Lee,S.E. and Ira,G. (2008) Sgs1
helicase and two nucleases Dna2 and Exo1 resect DNA
double-strand break ends. Cell, 134, 981–994.
8. Bothmer,A., Robbiani,D.F., Di Virgilio,M., Bunting,S.F., Klein,I.A.,
Feldhahn,N., Barlow,J., Chen,H.T., Bosque,D., Callen,E. et al. (2011)
Regulation of DNA end joining, resection, and immunoglobulin class
switch recombination by 53BP1. Mol. Cell, 42, 319–329.
9. Bunting,S.F., Callen,E., Wong,N., Chen,H.T., Polato,F., Gunn,A.,
Bothmer,A., Feldhahn,N., Fernandez-Capetillo,O., Cao,L. et al.
(2010) 53BP1 inhibits homologous recombination in Brca1-deficient
cells by blocking resection of DNA breaks. Cell, 141, 243–254.
10. Chapman,J.R., Barral,P., Vannier,J.B., Borel,V., Steger,M.,
Tomas-Loba,A., Sartori,A.A., Adams,I.R., Batista,F.D. and
Boulton,S.J. (2013) RIF1 is essential for 53BP1-dependent
nonhomologous end joining and suppression of DNA double-strand
break resection. Mol. Cell, 49, 858–871.
11. Escribano-Diaz,C., Orthwein,A., Fradet-Turcotte,A., Xing,M.,
Young,J.T., Tkac,J., Cook,M.A., Rosebrock,A.P., Munro,M.,
Canny,M.D. et al. (2013) A cell cycle-dependent regulatory circuit
composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair
pathway choice. Mol. Cell, 49, 872–883.
12. Feng,L., Fong,K.W., Wang,J., Wang,W. and Chen,J. (2013) RIF1
counteracts BRCA1-mediated end resection during DNA repair. J.
Biol. Chem., 288, 11135–11143.
13. Ayoub,N., Jeyasekharan,A.D., Bernal,J.A. and Venkitaraman,A.R.
(2008) HP1-beta mobilization promotes chromatin changes that
initiate the DNA damage response. Nature, 453, 682–686.
14. Baldeyron,C., Jacquemin,E., Smith,J., Jacquemont,C., De Oliveira,I.,
Gad,S., Feunteun,J., Stoppa-Lyonnet,D. and Papadopoulo,D. (2002)
A single mutated BRCA1 allele leads to impaired fidelity of double
strand break end-joining. Oncogene, 21, 1401–1410.
15. Baldeyron,C., Soria,G., Roche,D., Cook,A.J. and Almouzni,G.
(2011) HP1alpha recruitment to DNA damage by p150CAF-1
promotes homologous recombination repair. J. Cell Biol, 193, 81–95.
16. Dinant,C. and Luijsterburg,M.S. (2009) The emerging role of HP1 in
the DNA damage response. Mol Cell Biol, 29, 6335–6340.
17. Lee,Y.H., Kuo,C.Y., Stark,J.M., Shih,H.M. and Ann,D.K. (2013)
HP1 promotes tumor suppressor BRCA1 functions during the DNA
damage response. Nucleic Acids Res, 41, 5784–5798.
18. Luijsterburg,M.S., Dinant,C., Lans,H., Stap,J., Wiernasz,E.,
Lagerwerf,S., Warmerdam,D.O., Lindh,M., Brink,M.C.,
Dobrucki,J.W. et al. (2009) Heterochromatin protein 1 is recruited to
various types of DNA damage. J. Cell Biol., 185, 577–586.
19. Ayrapetov,M.K., Gursoy-Yuzugullu,O., Xu,C., Xu,Y. and Price,B.D.
(2014) DNA double-strand breaks promote methylation of histone
H3 on lysine 9 and transient formation of repressive chromatin. Proc.
Natl. Acad. Sci. U.S.A., 111, 9169–9174.
20. Brower-Toland,B., Riddle,N.C., Jiang,H., Huisinga,K.L. and
Elgin,S.C. (2009) Multiple SET methyltransferases are required to
maintain normal heterochromatin domains in the genome of
Drosophila melanogaster. Genetics, 181, 1303–1319.
21. Dodge,J.E., Kang,Y.K., Beppu,H., Lei,H. and Li,E. (2004) Histone
H3-K9 methyltransferase ESET is essential for early development.
Mol. Cell. Biol., 24, 2478–2486.
22. Loyola,A., Tagami,H., Bonaldi,T., Roche,D., Quivy,J.P., Imhof,A.,
Nakatani,Y., Dent,S.Y. and Almouzni,G. (2009) The
HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1
for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO
Rep., 10, 769–775.
23. Sarraf,S.A. and Stancheva,I. (2004) Methyl-CpG binding protein
MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to
DNA replication and chromatin assembly. Mol. Cell, 15, 595–605.
24. Schultz,D.C., Ayyanathan,K., Negorev,D., Maul,G.G. and
Rauscher,F.J. 3rd (2002) SETDB1: a novel KAP-1-associated histone
H3, lysine 9-specific methyltransferase that contributes to
HP1-mediated silencing of euchromatic genes by KRAB zinc-finger
proteins. Genes Dev., 16, 919–932.
25. Chapman,J.R., Sossick,A.J., Boulton,S.J. and Jackson,S.P. (2012)
BRCA1-associated exclusion of 53BP1 from DNA damage sites
underlies temporal control of DNA repair. J. Cell Sci., 125,
3529–3534.
26. Kakarougkas,A., Ismail,A., Katsuki,Y., Freire,R., Shibata,A. and
Jeggo,P.A. (2013) Co-operation of BRCA1 and POH1 relieves the
barriers posed by 53BP1 and RAP80 to resection. Nucleic Acids Res.,
41, 10298–10311.
27. Beucher,A., Birraux,J., Tchouandong,L., Barton,O., Shibata,A.,
Conrad,S., Goodarzi,A.A., Krempler,A., Jeggo,P.A. and Lobrich,M.
(2009) ATM and Artemis promote homologous recombination of
radiation-induced DNA double-strand breaks in G2. EMBO J., 28,
3413–3427.
28. Deckbar,D., Birraux,J., Krempler,A., Tchouandong,L., Beucher,A.,
Walker,S., Stiff,T., Jeggo,P.A. and Lobrich,M. (2007) Chromosome
breakage after G2 checkpoint release. J. Cell Biol., 176, 748–755.
29. Gunn,A. and Stark,J.M. (2012) I-SceI-based assays to examine
distinct repair outcomes of mammalian chromosomal double strand
breaks. Methods Mol. Biol., 920, 379–391.
30. Honma,M., Sakuraba,M., Koizumi,T., Takashima,Y., Sakamoto,H.
and Hayashi,M. (2007) Non-homologous end-joining for repairing
I-SceI-induced DNA double strand breaks in human cells. DNA
Repair (Amst), 6, 781–788.
31. Hill,S.J., Clark,A.P., Silver,D.P. and Livingston,D.M. (2014) BRCA1
pathway function in basal-like breast cancer cells. Mol. Cell. Biol., 34,
3828–3842.
32. Stiff,T., O’Driscoll,M., Rief,N., Iwabuchi,K., Lobrich,M. and
Jeggo,P.A. (2004) ATM and DNA-PK function redundantly to
phosphorylate H2AX following exposure to ioninsing radiation.
Cancer Res., 64, 2390–2396.
33. Chaumeil,J., Augui,S., Chow,J.C. and Heard,E. (2008) Combined
immunofluorescence, RNA fluorescent in situ hybridization, and
DNA fluorescent in situ hybridization to study chromatin changes,
transcriptional activity, nuclear organization, and X-chromosome
inactivation. Methods Mol. Biol., 463, 297–308.
34. Shakya,R., Reid,L.J., Reczek,C.R., Cole,F., Egli,D., Lin,C.S.,
deRooij,D.G., Hirsch,S., Ravi,K., Hicks,J.B. et al. (2011) BRCA1
tumor suppression depends on BRCT phosphoprotein binding, but
not its E3 ligase activity. Science, 334, 525–528.
35. Panier,S. and Durocher,D. (2013) Push back to respond better:
regulatory inhibition of the DNA double-strand break response. Nat.
Rev. Mol. Cell. Biol., 14, 661–672.
36. Kakarougkas,A. and Jeggo,P.A. (2014) DNA DSB repair pathway
choice: an orchestrated handover mechanism. Br. J. Radiol., 87,
20130685.
